GlaxoSmithKline Pharmaceuticals Limited Share Price NSE India S.E.
Equities
GLAXO
INE159A01016
Pharmaceuticals
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2,117 INR | -0.53% | +8.91% | +11.89% |
04-25 | GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology | RE |
03-22 | GlaxoSmithKline Pharmaceuticals Limited Receives Orders from Government Authorities | CI |
Sales 2024 * | 33.65B 403M 32.17B | Sales 2025 * | 36.49B 438M 34.89B | Capitalization | 361B 4.33B 345B |
---|---|---|---|---|---|
Net income 2024 * | 6.06B 72.7M 5.8B | Net income 2025 * | 7.68B 92.07M 7.34B | EV / Sales 2024 * | 10.7 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 9.9 x |
P/E ratio 2024 * |
53.1
x | P/E ratio 2025 * |
47.1
x | Employees | 3,680 |
Yield 2024 * |
1.42% | Yield 2025 * |
1.48% | Free-Float | 24.42% |
1 day | -0.23% | ||
1 week | +8.91% | ||
Current month | +9.10% | ||
1 month | +6.92% | ||
3 months | -2.75% | ||
6 months | +48.55% | ||
Current year | +11.89% |
Managers | Title | Age | Since |
---|---|---|---|
Bhushan Akshikar
CEO | Chief Executive Officer | 54 | 30/11/22 |
Juby Chandy
DFI | Director of Finance/CFO | - | 31/03/22 |
Simrat Sohal
CMP | Compliance Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Renu Sud Karnad
CHM | Chairman | 70 | 31/03/19 |
Manu Anand
BRD | Director/Board Member | 64 | 15/05/22 |
Director/Board Member | 74 | 29/03/15 |
Date | Price | Change | Volume |
---|---|---|---|
29/04/24 | 2,117 | -0.53% | 98 475 |
26/04/24 | 2,129 | +3.05% | 228,118 |
25/04/24 | 2,066 | -0.56% | 190,449 |
24/04/24 | 2,077 | +6.70% | 278,853 |
23/04/24 | 1,947 | -0.17% | 135,413 |
Delayed Quote NSE India S.E., April 29, 2024 at 06:20 am
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- GLAXO Stock
- GLAXO Stock